title: High activity of rituximab combined with cladribine and cyclophosphamide in a patient with pulmonary lymphomatoid granulomatosis and bone marrow involvement.
authors.forename: Tadeusz
authors.initials: T
authors.lastname: Robak
authors.forename: Radzisław
authors.initials: R
authors.lastname: Kordek
authors.forename: Halina
authors.initials: H
authors.lastname: Urbanska-Rys
authors.forename: Pawel
authors.initials: P
authors.lastname: Robak
authors.forename: Jacek
authors.initials: J
authors.lastname: Bartkowiak
authors.forename: Andrzej
authors.initials: A
authors.lastname: Bednarek
authors.forename: Cezary
authors.initials: C
authors.lastname: Chudobinski
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Chojnowski
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001855:Bone Marrow Diseases; D017338:Cladribine / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008171:Lung Diseases; D008230:Lymphomatoid Granulomatosis / Q000188:drug therapy* / Q000473:pathology; D008875:Middle Aged; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D017338:Cladribine; D000069283:Rituximab; D003520:Cyclophosphamide